Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
SOPHiA GENETICS S.A.

SOPHiA GENETICS S.A. (SOPH) Stock Overview

Explore SOPHiA GENETICS S.A.’s financial performance, market position, analyst ratings, and future outlook.

SOPH●NASDAQ
HealthcareMedical - Healthcare Information Services
$5.72
$0.33(5.45%)
U.S. Market opens in 63h 24m

SOPHiA GENETICS S.A. (SOPH)

Meyka AI Score

Z

Key Financials

Market Cap393.2M
P/E Ratio-4.89
EPS (TTM)$-0.52
ROE-1.41%
Fundamental Analysis

AI Price Forecasts

1 Month$5.25
3 Months$6.32
1 Year Target$5.97

SOPH Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of SOPHiA GENETICS S.A. (NASDAQ: SOPH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, SOPHiA GENETICS S.A.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SOPH on the NASDAQ shows an RSI of 51.10, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.97 for the NASDAQ listing.

Key metrics behind SOPHiA GENETICS S.A.'s NASDAQ-traded stock include a P/E ratio of -4.89 and a market capitalization of 393.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SOPH on the NASDAQ.

Price Performance (NASDAQ: SOPH)

1-Day Change
-5.45%
5-Day Change
-1.89%
1-Month Change
3.62%
3-Month Change
17.94%
6-Month Change
6.72%
Year-to-Date (YTD) Change
22.48%
1-Year Change
58.45%
3-Year Change
45.18%
5-Year Change
-66.35%
All-Time (Max) Change
-65.87%

Contact Information

https://www.sophiagenetics.com
41 21 694 10 60
La Piece 12, Rolle, VD, 1025

Company Facts

4,150 Employees
IPO DateJul 23, 2021
CountryCH
Actively Trading

Frequently Asked Questions